{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:05:31Z","timestamp":1790975131166,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.vaccine.2021.03.089","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T08:45:17Z","timestamp":1618303517000},"page":"2620-2627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["An open-label, comparative, single dose, clinical Phase \u2160 study to assess the safety and immunogenicity of typhoid conjugate vaccine (Vi-CRM197) in healthy Filipino adults"],"prefix":"10.1016","volume":"39","author":[{"given":"Seuk Keun","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong Ok","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Wha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il Nam","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeseon","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chankyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.vaccine.2021.03.089_b0005","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.03.089_b0010","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0140-6736(98)09001-1","article-title":"Typhoid fever in children aged less than 5 years","volume":"354","author":"Sinha","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2021.03.089_b0015","first-page":"346","article-title":"The global burden of typhoid fever. Bull World Health Organ","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2021.03.089_b0020","first-page":"957","article-title":"Vaccination against typhoid fever: Present status","volume":"72","author":"Ivanoff","year":"1994","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2021.03.089_b0025","doi-asserted-by":"crossref","unstructured":"World Health Organization. Typhoid vaccines: WHO position paper, March 2018 \u2013 Recommendations. Vaccine 2019;37:214\u20136. https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.022.","DOI":"10.1016\/j.vaccine.2018.04.022"},{"issue":"18","key":"10.1016\/j.vaccine.2021.03.089_b0030","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1016\/j.vaccine.2005.07.111","article-title":"Vaccines against typhoid fever","volume":"24","author":"Guzman","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2021.03.089_b0035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0264-410X(95)00186-5","article-title":"Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization","volume":"14","author":"Klugman","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.03.089_b0040","article-title":"Vaccines for preventing typhoid fever","volume":"2018","author":"Milligan","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"8541","key":"10.1016\/j.vaccine.2021.03.089_b0045","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(87)90480-6","article-title":"Large-Scale Field Trial of Ty21a Live Oral Typhoid Vaccine in Enteric-Coated Capsule Formulation","volume":"329","author":"Levine","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2021.03.089_b0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0264-410X(99)00231-5","article-title":"Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine","volume":"17","author":"Levine","year":"1999","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2021.03.089_b0055","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1128\/iai.59.11.4291-4293.1991","article-title":"Immunogenicity of Salmonella typhi Ty21a vaccine for young children","volume":"59","author":"Murphy","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2021.03.089_b0060","doi-asserted-by":"crossref","unstructured":"Mitra M, Shah N, Ghosh A, Chatterjee S, Kaur I, Bhattacharya N, et al. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph\u2122) in Indian children: School based cluster randomized study 2016;5515. https:\/\/doi.org\/10.1080\/21645515.2015.1117715.","DOI":"10.1080\/21645515.2015.1117715"},{"issue":"15","key":"10.1016\/j.vaccine.2021.03.089_b0065","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.vaccine.2013.02.006","article-title":"A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned","volume":"31","author":"Szu","year":"2013","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2021.03.089_b0070","doi-asserted-by":"crossref","first-page":"e25398","DOI":"10.1371\/journal.pone.0025398","article-title":"Safety, Immunogenicity and Dose Ranging of a New Vi-CRM197 Conjugate Vaccine against Typhoid Fever: Randomized Clinical Testing in Healthy Adults","volume":"6","author":"van Damme","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.03.089_b0075","doi-asserted-by":"crossref","unstructured":"Canh DG, Lin FK, Thiem VD, Trach DD, Trong ND, Mao ND, et al. Effect of Dosage on Immunogenicity of a Vi Conjugate Vaccine Injected Twice into 2- to 5-Year-Old Vietnamese Children \u2020 2004;72:6586\u20138. https:\/\/doi.org\/10.1128\/IAI.72.11.6586.","DOI":"10.1128\/IAI.72.11.6586-6588.2004"},{"key":"10.1016\/j.vaccine.2021.03.089_b0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2012.06673.x","article-title":"Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM197 conjugate vaccine","volume":"1263","author":"Gruber","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"10.1016\/j.vaccine.2021.03.089_b0085","doi-asserted-by":"crossref","first-page":"e868","DOI":"10.1016\/j.ijid.2010.03.017","article-title":"Safety and immunogenicity of an investigational quadrivalent meningococcal CRM197 conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America","volume":"14","author":"Stamboulian","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2021.03.089_b0090","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/21645515.2015.1086048","article-title":"Potential protective immunogenicity of tetanus toxoid, diphtheria toxoid and Cross Reacting Material 197 (CRM197) when used as carrier proteins in glycoconjugates","volume":"12","author":"Br\u00f6ker","year":"2016","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2021.03.089_b0095","unstructured":"World Health Organization n.d. https:\/\/www.who.int\/immunization\/diseases\/typhoid\/en\/."},{"key":"10.1016\/j.vaccine.2021.03.089_b0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biologicals.2018.09.001","article-title":"Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG","volume":"56","author":"Rijpkema","year":"2018","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2021.03.089_b0105","unstructured":"Rijpkema S, Hockley J, Logan A, Rigsby P, Atkinson E, Jin C, et al. Geneva, 17 to 20 October 2017 A WHO collaborative study to evaluate a candidate International Standard for 2017."},{"issue":"5","key":"10.1016\/j.vaccine.2021.03.089_b0110","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1080\/21645515.2016.1261772","article-title":"Comparative evaluation of a newly developed 13-valent pneumococcal conjugate vaccine in a mouse model","volume":"13","author":"Park","year":"2017","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2021.03.089_b0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.micpath.2016.05.013","article-title":"Serum bactericidal assay for the evaluation of typhoid vaccine using a semi-automated colony-counting method","volume":"97","author":"Jang","year":"2016","journal-title":"Microb Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21004059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21004059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:55:52Z","timestamp":1759402552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21004059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":23,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0264410X21004059"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.03.089","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An open-label, comparative, single dose, clinical Phase \u2160 study to assess the safety and immunogenicity of typhoid conjugate vaccine (Vi-CRM197) in healthy Filipino adults","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.03.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}